looks like more outside support coming in for Benitec alongside KSS on Dirk's blog. nice to have others doing our heavy lifting for a change!
"
Terry Chrisomalis said...
I'm writing an article for Benitec and how their technology works against the hepatitis C. I agree with the poster above you should wait to see the results before writing off Benitec. A lot of the other biotechs fail to target hepatitis C virus because they are only able to target one genome allowing the HCV to obtain a resistance during treatment. Benitec has established its technology to target all 3 genomes at the same time, not allowing the HCV to be able to gain resistance to the treatment. This knockdown in resistance of treatment along with DNA directed RNAi gene knockdown should merit enough efficacy to achieve proper status. But like the other poster said if you wanna write off Benitec that's fine its the other people who may reap the rewards.
February 22, 2014 at 7:53 PM
"
Add to My Watchlist
What is My Watchlist?